Research programme: BRD4 targeting therapeutics - DeepCure
Alternative Names: Bromodomain-containing protein 4 targeting therapeutics - DeepCureLatest Information Update: 27 Mar 2023
At a glance
- Originator DeepCure
- Class Eye disorder therapies; Skin disorder therapies; Small molecules
- Mechanism of Action BRD4 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Eye disorders; Skin disorders; Unspecified
Most Recent Events
- 22 Mar 2023 Early research in Eye disorders in USA (Ophthalmic) (DeepCure pipeline, March 2023)
- 22 Mar 2023 Early research in Skin disorders in USA (Topical) (DeepCure pipeline, March 2023)
- 22 Mar 2023 Early research in unspecified indication in USA (PO) (DeepCure pipeline, March 2023)